Aprecia Pharmaceuticals Revenue and Competitors

Blue Ash, OH USA

Location

$158.4M

Total Funding

3D

Industry

Estimated Revenue & Valuation

  • Aprecia Pharmaceuticals's estimated annual revenue is currently $12.9M per year.(i)
  • Aprecia Pharmaceuticals's estimated revenue per employee is $170,000
  • Aprecia Pharmaceuticals's total funding is $158.4M.

Employee Data

  • Aprecia Pharmaceuticals has 76 Employees.(i)
  • Aprecia Pharmaceuticals grew their employee count by 41% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.9M7641%$158.4MN/A
#2
$142.9M66214%$1.4MN/A
#3
$1M100%N/AN/A
#4
$20.7M122-8%$28.7MN/A
#5
$72.7M3425%N/AN/A
#6
$8.3M5450%N/AN/A
Add Company

Aprecia, The 3DP Pharmaceutical Company, expects to use its ZipDose® Technology to transform the way people take medicine. Its first innovation, ZipDose Technology can be combined with a wide variety of active pharmaceutical ingredients to create rapidly disintegrating oral dosage forms that are easy to take and easy to administer. Aprecia is committed to enhancing the patient experience through novel approaches to drug delivery that address unmet treatment needs to eliminate patient suffering and caregiver burden.

keywords:N/A

$158.4M

Total Funding

76

Number of Employees

$12.9M

Revenue (est)

41%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aprecia Pharmaceuticals News

2022-04-13 - Dr. Mike Gosselin Selected to Lead Aprecia?s Product ...

D., as Vice President of Pharmaceutical Development. Gosselin will oversee product development from early innovation to commercial production at...

2022-04-06 - In Leap Forward, Triastek Takes 3D-Printed Cardiovascular ...

Currently, there is only one 3D printed drug approved by the FDA, Aprecia Pharmaceuticals' Spritam, which is used in the treatment of...

2020-11-18 - Purdue University Receives 3DP Equipment from Aprecia Pharmaceuticals

WEST LAFAYETTE, Ind. and CINCINNATI, Nov. 18, 2020 /PRNewswire/ -- Purdue University continues to make giant leaps in innovation with the recent 3D printing (3DP) equipment donation from its industry partner Aprecia Pharmaceuticals. The donated equipment will enable research across multiple si ...

2016-07-05 - Aprecia Pharmaceuticals Receives $30M Debt Financing

Aprecia Pharmaceuticals Company, a Langhorne, PA-based commercial stage pharmaceutical company, entered into an up to $30 million debt financing agreement with Hercules Capital, Inc. (NYSE: HTGC). The company received initial funding of $20m under the debt financing agreement has the option to ...

2016-07-05 - Aprecia Pharmaceuticals Raises $30 Million from Hercules Capital

Aprecia Pharmaceuticals Company (Aprecia), a commercial stage pharmaceutical company developing, manufacturing and marketing fast melt formulations of high dose pharmaceuticals, today announced that it has entered into an up to $30 million debt financing agreement with Hercules Capital, Inc.. Ap ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M848%N/A
#2
$14.7M9010%N/A
#3
$20.2M967%N/A
#4
$75M11458%N/A
#5
$41.7M1183%N/A

Aprecia Pharmaceuticals Executives


NameTitle
Chris GilmoreCEO
Rob WillifordCOO
Karen SchreibeisExecutive Assistant To Chief Executive Officer
Jae YooChief Technology Officer
Michael RohlfsSVP, Business Operations & CFO
Amol MatharuChief Scientific Officer
Don WetherholdSr Executive Advisor & SVP
Kathi RinesmithSenior Vice President, Regulatory Affairs
Patti WrightSenior Vice President of Regulatory Affairs and Quality Assurance
Thomas WestVP, Pharmaceutical Development
Kyle SmithVice President Operations
Michael GosselinVice President of Pharmaceutical Development
Kirk DonaldsonVice President Of Business Development & Alliance Management
Garry HedgepethVice President Quality Assurance
Angie StewartVice President
Patrick StaudtVice President Operations
Michael RohlfsSVP, Business Operations & CFO
Kimberly EggersVP Medical and Clinical Affairs